LTD.;SICHUAN KELUN PHARMACEUTICAL RESEARCH INSTITUTE CO.
发明人:
Zhengxing Su,Likai Yang,Dong Zhao,Yujun Wang,Fengying Shan,Kexing Wang,Lichun Wang,Jingyi Wang
申请号：
US16321591
公开号：
US20200108022A1
申请日:
2017.09.21
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed herein is an albumin pharmaceutical composition, comprising albumin and at least one amino acid having a relative molecular mass of 145-175. Clinically, the albumin pharmaceutical composition can effectively reduce undesirable responses, such as rash, urticaria, anaphylaxis and possible immune responses in the human body caused by albumin polymers and dimers, thereby further ensuring the safety in clinical medication.
